Neonatal Sepsis: Clinical Trials

10 trials for Neonatal Sepsis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown, 1 active not recruiting, 1 not yet recruiting. 10 Phase 2, 5 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 4, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 35Active not recruiting 1, Completed 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 11Completed 1

Follow Neonatal Sepsis: new trials by email Literature Review of Neonatal Sepsis trials Research Report on Neonatal Sepsis

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
GBS-NN/NN2 vaccine - Streptococcus Agalactiae Infection, Neonatal Sepsis
Phase 2 / Phase 3Active not recruitingMinervax ApS1372025-03-072026-09-04
Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock
Methylene Blue, Placebo - Neonatal Sepsis, Shock, Septic
Phase 2 / Phase 3Not yet recruitingPost Graduate Institute of Medical Education and Research, Chandigarh1302024-03-152024-03-12
A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
Chlorhexidine Topical Cream, Methylated Spirit - Neonatal Sepsis, Omphalitis
Phase 2CompletedSheikh Zayed Federal Postgraduate Medical Institute3002020-09-122023-08-23
Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS)
Olive Oil Massage - Sepsis, Pre-Term
Phase 2 / Phase 3UnknownKing Abdullah International Medical Research Center3002020-09-012021-01-20
Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate
Methylene Blue - Neonatal Sepsis, Refractory Shock
Phase 2UnknownAin Shams University362019-02-192019-10-01
Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis
Standard of Care + Fosfomycin, PK, Analysis of Bacterial Isolates - Neonatal SEPSIS
Phase 2CompletedDrugs for Neglected Diseases1202018-03-152020-02-17
Neonatal Vancomycin Trial
Vancomycin - Late Onset Neonatal Sepsis
Phase 2TerminatedPENTA Foundation2422017-02-272020-09-09
Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
Melatonin 10 mg, Conventional treatment of neonatal sepsis - Neonatal Sepsis
Phase 1 / Phase 2CompletedMohamed Hussein Metwally552015-11-262017-09-27
Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at Birth
0.25% chlorhexidine, sterile water - Neonatal Sepsis, Neonatal Mortality Rate
Phase 2 / Phase 3WithdrawnAll India Institute of Medical Sciences2012-11-012016-07-18
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
Ampicillin + gentamicin - Chorioamnionitis, Puerperal Endometritis
Phase 2 / Phase 3CompletedHospital de Santa Maria, Portugal1612008-10-012016-11-28

Narrower conditions

Sepsis (3)  ·  Shock, Septic (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Chorioamnionitis (1)  ·  Endometritis (1)  ·  Fetal Membranes, Premature Rupture (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Meningitis (1)  ·  Pneumonia (1)  ·  Premature Birth (1)  ·  Shock (1)  ·  Streptococcal Infections (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10)  ·  Infant, Newborn, Diseases (10)  ·  Inflammation (10)  ·  Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Systemic Inflammatory Response Syndrome (10)  ·  Infections (9)  ·  Sepsis (7)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Obstetric Labor Complications (2)  ·  Pregnancy Complications (2)  ·  Urogenital Diseases (2)  ·  Adnexal Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Fetal Diseases (1)

Interventions

Methylene Blue (2)  ·  Ampicillin (1)  ·  Chlorhexidine (1)  ·  Fosfomycin (1)  ·  Gentamicins (1)  ·  Melatonin (1)  ·  Saline Solution (1)  ·  Standard of Care (1)  ·  Terlipressin (1)  ·  Vancomycin (1)

Sponsors

Ain Shams University (1)  ·  All India Institute of Medical Sciences (1)  ·  Drugs for Neglected Diseases (1)  ·  Hospital de Santa Maria, Portugal (1)  ·  King Abdullah International Medical Research Center (1)  ·  Minervax ApS (1)  ·  Mohamed Hussein Metwally (1)  ·  PENTA Foundation (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  Sheikh Zayed Federal Postgraduate Medical Institute (1)

Countries

India (2)  ·  Denmark (1)  ·  Egypt (1)  ·  Estonia (1)  ·  Greece (1)  ·  Italy (1)  ·  Kenya (1)  ·  Pakistan (1)  ·  Portugal (1)  ·  Saudi Arabia (1)  ·  South Africa (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Filipa Faria Vaz Passos, Dr (1)  ·  James A Berkley, Prof (1)  ·  Jubara Alallah (1)  ·  Mike Sharland, MD, FRCPCH (1)  ·  Sourabh Dutta, MD, PhD (1)  ·  Vinod K Paul, MD, PhD (1)

Results publications

PMID 11588440, PMID 12500513, PMID 12519925, PMID 14759425, PMID 16134766, PMID 17698886, PMID 18477932, PMID 21246318, PMID 23090521, PMID 26683506, PMID 27673307, PMID 28723883, PMID 29151412, PMID 29508706, PMID 29936590, PMID 30231909, PMID 32270211, PMID 32453920, PMID 32520577, PMID 33855449, PMID 34719443, PMID 34843669, PMID 35078765, PMID 35107141, PMID 36237547, PMID 36705345, PMID 36915146, PMID 8648456, PMID 9250657